Cargando…

Dimerization of the Sodium/Iodide Symporter

Background: The ability of thyroid follicular epithelial cells to accumulate iodide via the sodium/iodide symporter (NIS) is exploited to successfully treat most thyroid cancers, although a subset of patients lose functional NIS activity and become unresponsive to radioiodide therapy, with poor clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Rebecca J., Fletcher, Alice, Brookes, Katie, Nieto, Hannah, Alshahrani, Mohammed M., Mueller, Jonathan W., Fine, Nicholas H.F., Hodson, David J., Boelaert, Kristien, Read, Martin L., Smith, Vicki E., McCabe, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2019
Materias:	Thyroid Economy: Regulation, Cell Biology, and Thyroid Hormone Metabolism and Action
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797079/ https://www.ncbi.nlm.nih.gov/pubmed/31310151 http://dx.doi.org/10.1089/thy.2019.0034

Ejemplares similares

Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes
por: Koumarianou, Petrina, et al.
Publicado: (2022)

OR28-03 Drug Repurposing Identifies Inhibitors of the Proteostasis Network to Augment Radioiodine Uptake in Combinatorial Approaches Targeting Thyroid Cancer
por: Read, Martin L, et al.
Publicado: (2020)

OR14-05 Taking Advantage Of The Interleukin-6-Biology In Differentiated Thyroid Cancer To Stimulate Sodium Iodide Symporter (NIS)-mediated Iodide Uptake In Engineered Mesenchymal Stem Cells
por: Florentine Koehler, Viktoria, et al.
Publicado: (2023)

MON-512 The Anti-Cancer Agent, Homoharringtonine, Induces the Sodium Iodide Symporter (NIS) Gene Expression in Culture Cells from Papillary Thyroid Cancer, as Well as Non-Thyroid Cancers
por: Kato, Kanako
Publicado: (2020)

Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha
por: Freudenthal, Bernard, et al.
Publicado: (2019)

Transcriptome Network Analysis Reveals Aging-Related Mitochondrial and Proteasomal Dysfunction and Immune Activation in Human Thyroid
por: Cho, Byuri Angela, et al.
Publicado: (2018)

Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant Proteins
por: Moran, Carla, et al.
Publicado: (2017)

Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi
por: Di Cicco, Emery, et al.
Publicado: (2021)

Thyroid Hormone Transporters in a Human Placental Cell Model
por: Chen, Zhongli, et al.
Publicado: (2022)

Maternal Administration of the CNS-Selective Sobetirome Prodrug Sob-AM2 Exerts Thyromimetic Effects in Murine MCT8-Deficient Fetuses
por: Valcárcel-Hernández, Víctor, et al.
Publicado: (2023)

Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter
por: Read, Martin L., et al.
Publicado: (2022)

Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension
por: Jankauskas, Stanislovas S., et al.
Publicado: (2020)

Association of thyroid hormones with blood pressure and arterial stiffness in the general population: The Dali study
por: Jamal, Md Tasneem, et al.
Publicado: (2020)

Treatment of Graves’ Disease With a Combination of Low Iodine Diet and Potassium Iodide Plus Radioactive Iodine Treatment
por: Ebrahim, Ismail, et al.
Publicado: (2021)

OR26-05 Long-term Mortality And Cardiometabolic Effects Of Treatment For Hyperthyroidism: EGRET Study
por: Torlinska, Barbara, et al.
Publicado: (2023)

SAT526 Limited Utility of Routine Neck Ultrasound Follow-up in Advanced Stage Differentiated Thyroid Cancer
por: Munro, Vicki, et al.
Publicado: (2023)

SAT459 Teprotumumab Pooled Efficacy From The European Study Sites Participating In The Phase 2, OPTIC (Phase 3) And OPTIC-X Pivotal Trials
por: Kahaly, George J, et al.
Publicado: (2023)

SAT471 Hearing-Related Adverse Events in Teprotumumab Oncology Clinical Trials
por: Smith, Terry J, et al.
Publicado: (2023)

RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022)

SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023)

SAT466 Inactive Thyroid Eye Disease Patient Journey
por: Cockerham, Kimberly, et al.
Publicado: (2023)

FRI543 Effect Of Vitamin D Replacement On Thyroid Autoimmunity And thyroid Functions In Subclinical Hypothyroid And Vitamin D Deficient Patients: A Randomized Controlled Trial
por: Aljohani, Naji J
Publicado: (2023)

OR18-01 Effect of Teprotumumab on Proptosis Reduction Across Various Demographic Sub-Groups
por: Kahaly, George J, et al.
Publicado: (2020)

PSAT296 Graves’ Disease and Hurthle Cell Carcinoma: A Rare Presentation
por: Bhatt, Plukshi J, et al.
Publicado: (2022)

OR11-4 Teprotumumab Markedly Improves Disease-related Quality of Life: Lessons From Two Randomized, Placebo-controlled Trials
por: Douglas, Raymond S, et al.
Publicado: (2022)

MON-437 False Positive I-131 Uptake
por: Yadav, Pavan Rajendra, et al.
Publicado: (2020)

SAT482 A Case of Falsely Elevated Free T4 and Free T3 Levels Caused by Human Anti Mouse Antibodies.
por: Romao, Isabela J, et al.
Publicado: (2023)

FRI474 Panhypopituitarism And Central Hypothyroidism Presenting As Myoclonus And Hyperreflexia, An Unusual Presentation Likely Related To Thyrotropin-releasing Hormone
por: Nadeem, Ifrah, et al.
Publicado: (2023)

OR01-04 Kruppel-Like Factors 9 and 13 Cooperate to Maintain Mammalian Neuronal Differentiation
por: Avila-Mendoza, Jose, et al.
Publicado: (2020)

MON-492 Should Isthmic Thyroid Nodule Be Included in ACR TI-RADS Points in Predicting Thyroid Cancer?
por: Jasim, Sina, et al.
Publicado: (2020)

SAT539 Thyroid Cancer Presenting as Aspiration Pneumonia
por: Aslam, Sadia, et al.
Publicado: (2023)

FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
por: Maria Bignoli, Daniela Laura, et al.
Publicado: (2023)

THU663 Therapeutic Plasma Exchange In Refractory Atrial Fibrillation Secondary To Thyroid Storm.
por: Mohammed ALShehri, Sara, et al.
Publicado: (2023)

FRI497 Thyroid Storm And Recurrent Myopericarditis
por: Gomez D' Aza, Danelly J, et al.
Publicado: (2023)

MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)
por: Wirth, Lori J, et al.
Publicado: (2020)

SUN-425 Indiscriminate Thyroid Function Testing on Acute Hospital Admissions Reveals a High Abnormality Rate Requiring Follow Up
por: McEvoy, Robert P, et al.
Publicado: (2020)

RF23 | PSAT300 The Curious Case of Abnormal Thyroid Function Tests: Think Streptavidin Interference
por: Kodali, Alimitha M, et al.
Publicado: (2022)

FRI508 A Case Of Durvalumab Induced Hypothyroidism
por: Cecilio La Riva, Estefania Del Valle, et al.
Publicado: (2023)

MON-LB88 Positive Predictive Value of TP53 Variants in Bethesda III/IV Thyroid Fine-Needle Aspirates
por: Livhits, Masha J, et al.
Publicado: (2020)

SUN-432 Utilizing Patient Online Forums to Capture Experiences and Perceptions Associated with the Use of Desiccated Thyroid Extract
por: Bonilla, Freddy J K Toloza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k1cc8i181b5b7i2m50i67r8i07